[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE194494T1 - Kombinierte zelluläre und immunsuppressive therapien - Google Patents

Kombinierte zelluläre und immunsuppressive therapien

Info

Publication number
ATE194494T1
ATE194494T1 AT92922624T AT92922624T ATE194494T1 AT E194494 T1 ATE194494 T1 AT E194494T1 AT 92922624 T AT92922624 T AT 92922624T AT 92922624 T AT92922624 T AT 92922624T AT E194494 T1 ATE194494 T1 AT E194494T1
Authority
AT
Austria
Prior art keywords
cells
immunosupressive
therapies
foreign
combined cellular
Prior art date
Application number
AT92922624T
Other languages
English (en)
Inventor
Stephen A Sherwin
Robert B Dubridge
Original Assignee
Cell Genesys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cell Genesys Inc filed Critical Cell Genesys Inc
Application granted granted Critical
Publication of ATE194494T1 publication Critical patent/ATE194494T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT92922624T 1991-10-21 1992-10-14 Kombinierte zelluläre und immunsuppressive therapien ATE194494T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78107591A 1991-10-21 1991-10-21
PCT/US1992/008969 WO1993007887A1 (en) 1991-10-21 1992-10-14 Combined cellular and immunosuppressive therapies

Publications (1)

Publication Number Publication Date
ATE194494T1 true ATE194494T1 (de) 2000-07-15

Family

ID=25121603

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92922624T ATE194494T1 (de) 1991-10-21 1992-10-14 Kombinierte zelluläre und immunsuppressive therapien

Country Status (11)

Country Link
US (1) US5670148A (de)
EP (1) EP0610345B1 (de)
JP (1) JPH07500343A (de)
AT (1) ATE194494T1 (de)
AU (1) AU2883192A (de)
CA (1) CA2121487A1 (de)
DE (1) DE69231250T2 (de)
DK (1) DK0610345T3 (de)
ES (1) ES2150424T3 (de)
GR (1) GR3034510T3 (de)
WO (1) WO1993007887A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2683725B1 (fr) * 1991-11-15 1995-07-07 Pasteur Institut Composition cellulaire pour le traitement des organismes humains ou animaux.
US20030152909A1 (en) * 1994-11-16 2003-08-14 Mitrani Eduardo N. In vitro micro-organs, and uses related thereto
US6063375A (en) * 1996-09-10 2000-05-16 Medical University Of South Carolina Semiallogeneic cell hybrids and related methods for treating cancer
US7687057B2 (en) 1998-01-09 2010-03-30 Yissum Research Development Company Of The Hebrew University Of Jerusalem In vitro micro-organs, and uses related thereto
WO1999038954A1 (en) 1998-02-02 1999-08-05 Johns Hopkins University School Of Medicine A universal immunomodulatory cytokine-expressing bystander cell line and related compositions and methods of manufacture and use
WO2004006831A2 (en) * 2002-07-12 2004-01-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method and device for inducing biological processes by micro-organs
US20030152562A1 (en) * 2001-10-23 2003-08-14 Yissum Research Development Company Of The Hebrew University Of Jerusalem Vitro micro-organs, and uses related thereto
AU2007229367B2 (en) * 1999-06-25 2011-02-03 Yissum Research Development Company Of The Hebrew University Of Jerusalem In Vitro Micro-Organs and Uses Related Thereto
AU2003271042C1 (en) * 1999-06-25 2008-06-26 Yissum Research Development Company Of The Hebrew University Of Jerusalem In Vitro Micro-Organs and Uses Related Thereto
US8501396B2 (en) 2001-11-05 2013-08-06 Medgenics Medical Israel Ltd. Dermal micro-organs, methods and apparatuses for producing and using the same
US8088568B2 (en) 2001-11-05 2012-01-03 Medgentics, Inc. Dermal micro-organs, methods and apparatuses for producing and using the same
US7468242B2 (en) 2001-11-05 2008-12-23 Medgenics, Inc. Dermal micro organs, methods and apparatuses for producing and using the same
KR101134434B1 (ko) 2003-05-01 2012-04-09 메드제닉스 인코포레이티드 진피 미세 기관, 그를 생산 및 이용하기 위한 방법 및 장치
KR101449587B1 (ko) 2006-09-14 2014-10-10 메드제닉스 메디칼 이스라엘 리미티드 장기 지속형 약물 제형
US8454948B2 (en) 2006-09-14 2013-06-04 Medgenics Medical Israel Ltd. Long lasting drug formulations
AU2011268458B2 (en) 2010-06-15 2014-06-12 Medgenics Medical Israel Ltd. Long lasting drug formulations
BR112013005711A2 (pt) 2010-09-08 2017-06-13 Univ Texas método para tratar um tumor, mutante, molécula de ácido nucleico isolada, construção de expressão, composição, e, método para administrar uma terapia
WO2018148224A1 (en) 2017-02-07 2018-08-16 Seattle Children's Hospital (dba Seattle Children's Research Institute) Phospholipid ether (ple) car t cell tumor targeting (ctct) agents
EP3589295B1 (de) 2017-02-28 2024-09-11 Endocyte, Inc. Zusammensetzungen und verfahren für car-t-zelltherapie
JP7417542B2 (ja) 2018-01-22 2024-01-18 シアトル チルドレンズ ホスピタル （ディービーエイ シアトル チルドレンズ リサーチ インスティテュート） Ｃａｒ ｔ細胞の使用方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4769317A (en) * 1983-06-14 1988-09-06 Hefton John M Process for growing human epidermis, product thereof
US4980286A (en) * 1985-07-05 1990-12-25 Whitehead Institute For Biomedical Research In vivo introduction and expression of foreign genetic material in epithelial cells
US5175004A (en) * 1988-12-27 1992-12-29 Matsumura Kenneth N Propagatable, new combinant cells for cellular replacement therapy
US5283058A (en) * 1990-08-30 1994-02-01 The General Hospital Corporation Methods for inhibiting rejection of transplanted tissue
WO1993002188A1 (en) * 1991-07-15 1993-02-04 Oklahoma Medical Research Foundation Universal donor cells

Also Published As

Publication number Publication date
GR3034510T3 (en) 2000-12-29
DE69231250T2 (de) 2001-03-15
AU2883192A (en) 1993-05-21
EP0610345A4 (de) 1997-01-15
EP0610345A1 (de) 1994-08-17
WO1993007887A1 (en) 1993-04-29
CA2121487A1 (en) 1993-04-29
JPH07500343A (ja) 1995-01-12
US5670148A (en) 1997-09-23
EP0610345B1 (de) 2000-07-12
DK0610345T3 (da) 2000-10-23
DE69231250D1 (de) 2000-08-17
ES2150424T3 (es) 2000-12-01

Similar Documents

Publication Publication Date Title
ATE194494T1 (de) Kombinierte zelluläre und immunsuppressive therapien
PT771147E (pt) Composições e métodos para imunidade celular tumoral in vivo melhorada
DK66692A (da) En mammal cytokin, il-11
DE69534528D1 (de) Mehrstufiger kaskade-erhöhungsimpfstoff
FI964033A0 (fi) Menetelmiä sairauden hoitamiseksi käyttäen Sertoli-soluja ja allografteja tai ksengrafteja
FR2709309B1 (fr) Compositions cellulaires, préparation et utilisations thérapeutiques.
DK0668772T3 (da) Specifik immunsystemmodulering
DK0683669T3 (da) Fremgangsmåder og præparater af en polymer (poloxamer) til cellereparation
EA199800272A1 (ru) Фактор, стимулирующий дендритные клетки
AR009560A1 (es) Prolongacion de la sobrevida de injertos con porfirinas
DE69110877D1 (de) Idiotypen-impfung gegen b-zell-lymphoma.
DK0914114T3 (da) Fremgangsmåder til behandling af type I-hypersensitivitet under anvendelse af monophosphoryl-lipid A
MX9400434A (es) Potenciamiento de temozolomida en celulas de tumores humanos.
ES2058343T3 (es) Piridinas disubstituidas.
IL114382A (en) Lymphotoxin for use as a medicament for cancer therapy and use thereof in the manufacture of such medicament
WO2002017935A3 (en) A method of transplantation using chemotherapy-treated allogeneic cells that enhance immune responses without graft versus host disease
ATE226087T1 (de) Verwendung von neuen zelltod inducierenden mitteln im synergismus mit interferon
PT765398E (pt) Populacao de celulas enriquecedoras em progenitores mieloides e linfoides e metodos de as fazer e utilizar
USD218327S (en) Cabinet or similar article
DK0697876T3 (da) Xenograftthymus
Szuromi Designer dendritic-cell therapy
AR019100A1 (es) Administracion de proteinas terapeuticas
Sparenberg In Alahiyi
Mowbray Judicial Review in Ireland
EP1048298A3 (de) Gemischter Chimerismus und Toleranz

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee